Categories
All News News

Neurovascular Devices/Interventional Neurology Market: Top Company Profiles, Market Drivers, Restraints, Opportunities and Forecast Analysis

Neurovascular Devices/Interventional Neurology Market by Product (Embolization(Coil, Flow Diverter), Stents, Balloon Occlusion Devices, Clot Retrievers, Microcatheters), Pathology (Stroke, Aneurysm, CAS, AVM) User (Hospital, ASC) – Global Forecasts to 2026 The neurovascular devices/ interventional neurology market size is expected to grow from an estimated USD 2.5 billion in 2021 to USD 3.8 billion by 2026, at a CAGR of 8.6%.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=203750

The neurovascular devices/interventional neurology market is dominated by a few major players that have an extensive country presence such as

Johnson & Johnson (US),

Medtronic PLC (Ireland),

Stryker Corporation (US),

Terumo Corporation (Japan),

Penumbra, Inc. (US),

and MicroPort Scientific Corporation (China) among others.

The growing target patient population, ongoing product development, and commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across the emerging markets, growth in market demand for effective neurovascular devices, increase in research in the field of neurovascular therapies, rise in demand for minimally invasive neurosurgical procedures, and increase in awareness among neurosurgeons about minimally invasive surgical procedures are high growth prospects for the neurovascular devices/ interventional neurology market during the forecast period.

Neurovascular Devices/Interventional Neurology Market research report is wide-ranging and object-oriented which is framed after the combination of an admirable industry experience, talent solutions, industry insight, and most modern tools and technology. A thorough analysis has been performed in this report to know the potential of the market in the present and the future prospects from various angles. This market report is built by chewing over several fragments of the present and upcoming market scenario because an utter way to forecast what the future holds is to comprehend the trend today. Neurovascular Devices/Interventional Neurology Market research report helps the clients get familiar with the various drivers and restraints influencing the industry.

“The aneurysm coiling & embolization devices segment is expected account for the largest share of the neurovascular devices/interventional neurology market from 2021 to 2026.

On the basis of product, the neurovascular devices/interventional neurology market is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neuro thrombectomy devices. The aneurysm coiling & embolization devices product segment, by type, is further segmented into embolic coils, flow diversion devices, and liquid embolic agents. The aneurysm coiling & embolization devices segment is estimated to account for the largest share of the neurovascular devices/interventional neurology market, by product, in 2021, owing to growing end-user preference for minimally invasive neurosurgical procedures and increasing market availability of embolic coils for neurovascular treatment.

“The cerebral aneurysm segment is estimated to account for the largest share of the global neurovascular devices/interventional neurology market from 2021 to 2026.

On the basis of pathology, the neurovascular devices/interventional neurology market is segmented into ischemic strokes, cerebral aneurysm, carotid artery stenosis, arteriovenous malformations & fistulas, and other diseases (including cavernous malformations and Moyamoya disease, among others). The cerebral aneurysm segment is estimated to account for the largest share of the global neurovascular devices/interventional neurology market, by pathology, in 2021, led by the growing adoption of minimally invasive neurosurgical procedures among neurosurgeons, increasing healthcare expenditure in emerging countries, and increasing incidence of risk factors (such as high blood pressure, cigarette smoking, high cholesterol, diabetes, and obesity).

“The ambulatory care centers segment is expected to grow at the highest CAGR from 2021 to 2026.

Based on end-user, the neurovascular devices/interventional neurology market has been segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories, and academic institutes. As of 2020, hospitals & surgical centers are estimated to account for the largest share of the global neurovascular devices/interventional neurology market in 2021, while ambulatory care centers are projected to register the highest CAGR during the forecast period. Growing patient preference for minimally invasive medical procedures, rising number of ambulatory surgery centers across developed countries, along with the ease of scheduling, the focused clinical staff, the improved productivity, and the increased safety, and efficacy of these centers, are the major factors that are expected to drive the growth of this end-user segment in the coming years.

“North America: The largest market in the neurovascular devices/interventional neurology industry.”  

North America accounted for the largest market share in the neurovascular devices/interventional neurology market in 2020. The neurovascular devices/interventional neurology market in North America is driven primarily by factors such as the growing target patient population for neurovascular diseases, rising awareness among neurosurgeons regarding the benefits offered by interventional neurology devices, and ongoing government initiatives to modernize & expand healthcare infrastructure. Additionally, the adoption of these devices has increased due to falling product prices, thereby further supporting the market growth in this region.

Breakdown of Primaries:

In-depth interviews have been conducted with various key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information, as well as to assess future market prospects. The distribution of primary interviews is as follows:

  • By Company Type: Tier 1- 48%, Tier 2- 36%, and Tier 3- 16%
  • By Designation: C-Level- 10%, Director Level- 14%, and Others- 76%
  • By Region: North America – 40%, Europe – 32%, Asia Pacific – 20%, Lain America –  5%, Middle East & Africa – 3%

*Others include sales managers, engineers, and regional managers.

Note: Tier 1 Company—Revenue > USD 5 billion, Tier 2 Company—Revenue between USD 1 and USD 5 billion, and Tier 3 Company—Revenue < USD 1 billion

Research Coverage:

The report defines, describes, and forecasts the neurovascular devices/interventional neurology market, by product, disease pathology, end-user, and region. It also offers a detailed qualitative and quantitative analysis of the market. The report provides a comprehensive review of the major market drivers, restraints, opportunities, and challenges. It also covers various important aspects of the market, which include the analysis of the competitive landscape, market dynamics, market estimates in terms of value and volume, and future trends in the neurovascular devices/interventional neurology market.

Why Buy this Report?

  • The report identifies and addresses the key markets for the neurovascular devices/interventional neurology market, which would help equipment manufacturers and service providers review the growth in demand.
  • The report helps system providers understand the pulse of the market and provides insights into drivers, restraints, opportunities, and challenges.
  • The report will help key players understand the strategies of their competitors better and help them in making better strategic decisions.

For More Information or Query or Customization Before Buying, Visit @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=203750

Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
Figure 1 Neurovascular Devices/Interventional Neurology Market Segmentation
1.3.2 Inclusions & Exclusions Of The Study
1.3.3 Years Considered For The Study
1.4 Currency
Table 1 Standard Currency Conversion Rates
1.5 Stakeholders
1.6 Summary Of Changes

2 Research Methodology
2.1 Research Data
Figure 2 Research Design
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 3 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
Figure 4 Breakdown Of Primaries: By Company Type, Designation, And Region
2.2 Market Estimation Methodology
Figure 5 Research Methodology: Hypothesis Building
2.2.1 Product-Based Market Estimation
2.2.2 Volume-Based Market Estimation
Figure 6 Market Size Estimation: Neurovascular Devices/Interventional Neurology Market
Figure 7 Cagr Projections: Supply-Side Analysis
2.3 Covid-19 Health Assessment
2.4 Covid-19 Economic Assessment
2.5 Assessment Of The Impact Of Covid-19 On The Economic Scenario
Figure 8 Criteria Impacting The Global Economy
Figure 9 Recovery Scenario Of The Global Economy
2.6 Assessment Of The Impact Of Covid-19 On The Economic Scenario In The Neurovascular Devices/Interventional Neurology Market
2.7 Data Triangulation
Figure 10 Data Triangulation
2.8 Research Assumptions
2.9 Research Limitations

3 Executive Summary
Figure 11 Neurovascular Devices/Interventional Neurology Market Size, By Product, 2021 Vs. 2026 (Usd Million)
Figure 12 Neurovascular Devices/Interventional Neurology Market Size, By Disease Pathology, 2021 Vs. 2026 (Usd Million)
Figure 13 Hospitals & Surgical Centers To Lead In Neurovascular Devices/ Interventional Neurology Applications During The Forecast Period
Figure 14 North America To Dominate The Neurovascular Devices/ Interventional Neurology Market During The Forecast Period

4 Premium Insights
4.1 Neurovascular Devices/Interventional Neurology Market Overview
Figure 15 Growing Target Patient Population To Drive Market Demand For Interventional Neurology Products
4.2 Europe: Neurovascular Devices/Interventional Neurology Market
Figure 16 Europe: Aneurysm Coiling & Embolization Devices To Lead Neurovascular Devices/Interventional Neurology Market
4.3 Neurovascular Devices/Interventional Neurology Product Market, By Region
Figure 17 Embolic Coils To Lead The Neurovascular Devices/Interventional Neurology Market
4.4 Neurovascular Devices/Interventional Neurology Market, By Disease Pathology
Figure 18 Cerebral Aneurysm To Dominate Neurovascular Devices/ Interventional Neurology Market, By Disease Pathology, 2021 Vs. 2026
4.5 Neurovascular Devices/Interventional Neurology Market, By Country
Figure 19 China And India To Be The Fastest-Growing Countries In The Global Neurovascular Devices/Interventional Neurology Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 20 Neurovascular /Interventional Neurology Devices Market: Drivers, Restraints, Opportunities, And Challenges
5.2.1 Drivers
5.2.1.1 Large Target Patient Population
Figure 21 Proportion Of Geriatric Population To Total World Population, By Country, 2020 Vs. 2030 (Million People)
5.2.1.2 Increasing Product Launches And Commercialization
Table 2 Product Approvals In The Neurovascular Devices Market, 2020–2021
5.2.1.3 Favorable Reimbursement Scenario
Table 3 Us: Reimbursement For Interventional Neurology Procedures, 2020
5.2.1.4 Expansion Of Healthcare Infrastructure Across Emerging Markets
Figure 22 Global Trend In Government Healthcare Expenditure (Gdp): Developed Vs. Developing Countries, 2015 Vs. 2019
5.2.1.5 Growth In Market Demand For Effective Neurovascular Devices
5.2.2 Restraints
5.2.2.1 Dearth Of Skilled Neurosurgeons
5.2.2.2 High Procedural Cost Of Neurovascular Surgeries And Related Products
5.2.3 Opportunities
5.2.3.1 Increase In The Number Of Research Activities In The Field Of Neurovascular Therapies
Figure 23 Ongoing Clinical Trials In The Neurovascular Devices/Interventional Neurology Market
5.2.3.2 Rise In Demand For Minimally Invasive Neurosurgical Procedures
5.2.4 Challenge
5.2.4.1 Stringent Regulations
5.3 Supply Chain Analysis
Figure 24 Supply Chain Analysis: Neurovascular Devices/Interventional Neurology Market, 2020
5.3.1 Role In Supply Chain
5.4 Ecosystem Analysis
5.5 Value Chain Analysis
Figure 25 Value Chain Analysis: Maximum Value Added During The Regulation And Distribution Stages
5.6 Porter’s Five Forces Analysis
5.6.1 Overview
Table 4 Neurovascular Devices/Interventional Neurology Market: Porter’s Five Forces Analysis
5.6.2 Threat Of New Entrants
Figure 26 Threat Of New Entrants
5.6.3 Threat Of Substitutes
Figure 27 Threat Of Substitutes
5.6.4 Bargaining Power Of Suppliers
Figure 28 Bargaining Power Of Suppliers
5.6.5 Bargaining Power Of Buyers
Figure 29 Bargaining Power Of Buyers
5.6.6 Degree Of Competition
Figure 30 Degree Of Competition
5.7 Regulatory Landscape
5.7.1 North America
5.7.1.1 Us
Table 5 Us Fda: Medical Device Classification
Table 6 Us: Medical Device Regulatory Approval Process
5.7.1.2 Canada
5.7.2 Europe
5.7.3 Apac
5.7.3.1 China
5.7.3.2 Japan
5.7.3.3 India
5.7.3.4 South Korea
5.8 Reimbursement Scenario
Table 7 Reimbursement Codes For Various Procedures As Of 2019
5.9 Pricing Trend Analysis
Table 8 Average Price Of Neurovascular Devices, By Country, 2020 (Usd)
5.10 Covid-19 Impact On Neurovascular/Interventional Neurology Devices Market
5.11 Patent Details
Table 9 Patent Details
Figure 31 Patent Analysis, 2011–2021

Read More……………….

Get Direct Order of this Report @ https://www.reportsnreports.com/purchase.aspx?name=203750

https://jumbonews.co.uk/